Search
for
Sort by
Research 961–990 of 1000+
- FINASTERIDE FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
- The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
- Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients
- Design and In Vitro Evaluation of Finasteride-Loaded Liquid Crystalline Nanoparticles for Topical Delivery
- Treatment of Recurrent Priapism in Sickle Cell Anemia With Finasteride: A New Approach
- Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia
- Antiandrogenic Therapy With Finasteride Attenuates Cardiac Hypertrophy and Left Ventricular Dysfunction
- Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism
- Effects of the 5α-Reductase Inhibitor Finasteride on Serum Levels of Gonadal, Adrenal, and Hypophyseal Hormones and its Clinical Significance: A Prospective Clinical Study
- C<sub>19</sub>and C<sub>21</sub>5<i>β</i>/5<i>α</i>Metabolite Ratios in Subjects Treated with the 5<i>α</i>-Reductase Inhibitor Finasteride: Comparison of Male Pseudohermaphrodites with Inherited 5<i>α</i>-Reductase Deficiency*
- Finasteride use in the male infertility population: effects on semen and hormone parameters
- Treatment with and withdrawal from finasteride alter ethanol intake patterns in male C57BL/6J mice: Potential role of endogenous neurosteroids?
- Chitosan-decorated polystyrene-b-poly(acrylic acid) polymersomes as novel carriers for topical delivery of finasteride
- A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
- Finasteride for female androgenetic alopecia
- Comparison of high-dose finasteride (5 mg/day) versus low-dose finasteride (2.5 mg/day) in the treatment of hirsutism
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
- A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers
- A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism
- Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism
- Finasteride as a therapy for hidradenitis suppurativa
- Finasteride in the treatment of hirsutism: new therapeutic perspectives
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- Propecia-induced spermatogenic failure: a report of two cases
- Intraoperative floppy-iris syndrome and finasteride intake
- The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia
- Tamoxifen for flutamide/finasteride-induced gynecomastia
- Design of Finasteride-Loaded Nanoparticles for Potential Treatment of Alopecia
- Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice.